Earth is ghetto8 billion roommates, zero security deposit1 in 3 households crushed by housing costsOne hospital bill from bankruptcyIncome inequality: above 0.40 and climbingLife expectancy: don't get too attachedAir quality: questionablePolitical polarization: surgingHomicide rates: location-dependentNow scoring 9 metrics — Gini coefficient addedRecommendation: do not move in
Policy Watchlist · Official Sources · US · UK · EU
EURegulationOfficial ✓September 7, 2026· European Commission

Commission approves €400 million German State aid to enhance insulin supply resilience

What happened

The European Commission, under EU State aid rules, approved a €400 million German measure. This funding will be paid to Sanofi-Aventis Deutschland GmbH as public service compensation. This compensation is for providing a service of general economic interest to strengthen the resilience of the supply of human insulin and insulin analogues.

Why it matters

This policy aims to ensure a more stable and reliable supply of essential insulins for patients. It addresses the resilience of the supply chain, which can help prevent future shortages of these critical medicines.

Who it affects

  • Sanofi-Aventis Deutschland GmbH
  • People relying on human insulin
  • People relying on insulin analogues
  • German public health system
Receipts

The receipts are official. The summary is ours.

Read on European Commission

Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.

More from EU